Li, Hua
Tang, Yingying
Chen, Xiaoping
Zhang, Mengge
Jiang, Feng
Zhu, Fangfang
Xie, Linghua
Wu, Hui
Xu, Qi
Chen, Qing
Xie, Shulan
Dai, Ange
Chen, Xinzhong
Article History
Received: 3 October 2024
Accepted: 28 January 2025
First Online: 17 February 2025
Declarations
:
: The study was approved by the Ethical Committee of Women’s Hospital, Zhejiang University School of Medicine (Hangzhou, China) (No. IRB-20220149-R) on April 21, 2022, and registered at Chinese Clinical Trials.gov (No. ChiCTR2200062228). The study was conducted from August 2022 to August 2023. All participants were informed of the purpose of the study and signed consent forms.
: Not applicable.
: The authors declare no competing interests.